- Home
- ACTU vs THCH Comparison
ACTU vs THCH Comparison
Compare ACTU & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- THCH
- Stock Information
- Founded
- ACTU 2015
- THCH 2018
- Country
- ACTU United States
- THCH China
- Employees
- ACTU N/A
- THCH N/A
- Industry
- ACTU
- THCH Blank Checks
- Sector
- ACTU
- THCH Finance
- Exchange
- ACTU NYSE
- THCH Nasdaq
- Market Cap
- ACTU 154.3M
- THCH 141.1M
- IPO Year
- ACTU 2024
- THCH N/A
- Fundamental
- Price
- ACTU $6.96
- THCH $2.98
- Analyst Decision
- ACTU Strong Buy
- THCH
- Analyst Count
- ACTU 1
- THCH 0
- Target Price
- ACTU $20.00
- THCH N/A
- AVG Volume (30 Days)
- ACTU 36.4K
- THCH 16.3K
- Earning Date
- ACTU 05-21-2025
- THCH 04-17-2025
- Dividend Yield
- ACTU N/A
- THCH N/A
- EPS Growth
- ACTU N/A
- THCH N/A
- EPS
- ACTU N/A
- THCH N/A
- Revenue
- ACTU N/A
- THCH $207,029,179.00
- Revenue This Year
- ACTU N/A
- THCH N/A
- Revenue Next Year
- ACTU N/A
- THCH N/A
- P/E Ratio
- ACTU N/A
- THCH N/A
- Revenue Growth
- ACTU N/A
- THCH N/A
- 52 Week Low
- ACTU $5.51
- THCH $2.78
- 52 Week High
- ACTU $11.73
- THCH $7.20
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- THCH 44.38
- Support Level
- ACTU N/A
- THCH $2.78
- Resistance Level
- ACTU N/A
- THCH $3.05
- Average True Range (ATR)
- ACTU 0.00
- THCH 0.21
- MACD
- ACTU 0.00
- THCH -0.02
- Stochastic Oscillator
- ACTU 0.00
- THCH 27.78
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.